MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$163,253K
Cash and cash
equivalents
$90,770K
Prepaid expenses and
other current assets
$13,281K
Total current assets
$267,304K
Property and equipment,
net
$32,720K
Other investments
$19,000K
Operating lease
right-of-use assets
$17,828K
Marketable securities,
non-current
$6,954K
Other non-current
assets
$5,234K
Restricted cash
$1,586K
Total assets
$350,626K
Total liabilities and
stockholders equity
$350,626K
Total stockholders
equity
$273,665K
Total liabilities
$76,961K
Accumulated deficit
-$1,643,707K
Accumulated other
comprehensive (loss) income
-$9K
Additional paid-in capital
$1,917,379K
Operating lease
liabilities, non-current
$39,487K
Total current
liabilities
$36,947K
Other non-current
liabilities
$527K
Common stock, value,
issued
$2K
Accrued liabilities and
other current...
$31,479K
Accounts payable
$5,468K
Back
Back
Balance Sheet
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)
source: myfinsight.com